USANA Health Sciences Inc...

27.26
0.29 (1.08%)
At close: Apr 01, 2025, 3:59 PM
27.70
1.61%
After-hours: Apr 01, 2025, 07:50 PM EDT

USANA Health Sciences Income Statement

Year FY24 FY23 FY22 FY21 FY20
Revenue 854.5M 921.01M 998.6M 1.19B 1.13B
Cost of Revenue 161.21M 176.69M 193.89M 217.9M 209.11M
Gross Profit 693.29M 744.32M 804.71M 968.57M 925.53M
Operating Income 66.32M 93.07M 107.61M 170.19M 176.49M
Interest Income 11.32M 9.64M 3.79M 2.52M 2.54M
Pretax Income 76.35M 102.45M 108.62M 170.64M 177.95M
Net Income 42.03M 63.79M 69.35M 116.5M 124.66M
Selling & General & Admin 263.27M 256.99M 697.1M 798.37M 749.04M
Research & Development n/a 11.45M 11.56M 11.11M 10.63M
Other Expenses 363.7M 382.81M 1.01M 450K 1.46M
Operating Expenses 626.97M 651.25M 697.1M 798.37M 749.04M
Interest Expense 281K 262K 192K 57K 507K
Selling & Marketing Expenses n/a n/a 434.79M 519.27M 487.86M
Cost & Expenses 788.18M 827.94M 890.99M 1.02B 958.15M
Income Tax 34.32M 38.66M 39.27M 54.14M 53.28M
Shares Outstanding (Basic) 19.06M 19.25M 19.25M 20.15M 21.16M
Shares Outstanding (Diluted) 19.16M 19.34M 19.31M 20.34M 21.26M
EPS (Basic) 2.20 3.31 3.60 5.78 5.89
EPS (Diluted) n/a n/a n/a n/a n/a
EBITDA 98.86M 123.11M 130.22M 192.89M 200.96M
Depreciation & Amortization 22.23M 20.39M 21.41M 22.19M 22.51M